mds - aml - 2020 spring virtual conference: when mds becomes aml - for high-risk mds patients
Published 1 year ago • 179 plays • Length 50:26Download video MP4
Download video MP3
Similar videos
-
49:51
mds - 2020 spring virtual conference: what's in an mds diagnosis?
-
55:36
ash 2020: aml secondary to mds - updates for patients
-
1:00:54
managing higher risk mdl and aml
-
1:36
innovations in mds and aml treatment
-
1:26:48
updates from ash 2020: promising treatment advances for mds and aml
-
33:29
higher-risk mds and aml: how new guidelines are changing diagnosis, classification and management
-
1:10:32
mds/mpn/aml session
-
3:14
hypomethylating agents in mds and aml
-
1:04:46
ash 2019 the latest in mds and secondary aml
-
22:08
the origin of relapses mds/aml - l shlush
-
1:01:45
new and emerging therapies for mds
-
1:27:42
precision medicine in mds and aml
-
1:50:31
toronto mds patient webinar
-
1:00:07
the therapeutic revolution in management of higher risk mds: a focus on immunotherapy
-
1:06:25
treatment of high risk mds and the indication for stem cell transplant
-
3:38
how serious a cancer is mds? what is the prognosis for mds?
-
1:41
the future of aml and mds diagnosis and treatment
-
4:26
david sallman: early results of 5f9 in aml and mds
-
2:34
new salvage treatment for aml/mds after allogeneic transplant: the viola trial